EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real‐World Predictors of Relapse‐Free Duration After Narrowband UVB in Pediatric Psoriasis: A Multicenter Study

Berna Solak iD, Burhan Engin iD, Zeynep Güngör iD, Ömer Faruk Tolun iD, Zafer Türkoğlu iD, Dilay Baştuğ iD, Harbiye Dilek Canat iD, Tubanur Çetinarslan iD, Aylin Türel Ermertcan iD, Selen Gezmen iD, Özge Zorlu iD, Hülya Albayrak iD und 2 weitere

Photodermatology, Photoimmunology & Photomedicine · 2026-03 · 42 (2)

DOI: 10.1111/phpp.70076 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, online erschienen am 12.02.2026. Verfasst von Berna Solak und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Türkiye. Hauptthemen laut MEDLINE: Psoriasis, Ultraviolet Therapy, Calcitriol, Dermatologic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Narrowband ultraviolet B (NB‐UVB) phototherapy is a well‐established, safe, and effective treatment for pediatric psoriasis; however, relapse after therapy remains a major challenge. Data regarding prognostic factors influencing remission durability in children are limited.

Objectives

To evaluate treatment response, relapse patterns, and predictors of relapse‐free duration in pediatric psoriasis patients treated with NB‐UVB phototherapy, with a particular focus on concomitant topical corticosteroid and calcipotriol use, and clinical features such as nail involvement.

Methods

This multicenter retrospective study included 114 pediatric psoriasis patients treated with NB‐UVB across six tertiary dermatology centers in Türkiye. Treatment response was defined as ≥ 75% improvement in the Psoriasis Area and Severity Index (PASI75). Relapse was defined as clinically significant recurrence requiring renewed NB‐UVB or systemic therapy within 6 months after treatment completion. Multivariable linear regression identified independent predictors of relapse‐free duration.

Results

Of 114 patients (mean age 12.2 ± 3.6 years; 52.6% male), 65.8% achieved PASI75 and 42.1% PASI90. Responders received significantly higher cumulative doses and more sessions than nonresponders ( p < 0.001). Relapse occurred in 24.0% of responders within 6 months. In multivariate analysis, concomitant topical corticosteroid use independently predicted longer relapse‐free duration ( β = 0.578, p = 0.001), whereas nail involvement predicted shorter remission ( β = −0.520, p = 0.002). Topical calcipotriol and disease subtype were not significant predictors. NB‐UVB was well tolerated, with mild erythema and pruritus as the most frequent adverse events (16.7%).

Conclusion

NB‐UVB phototherapy provides high efficacy and an acceptable safety profile in pediatric psoriasis. Concomitant topical corticosteroid use may prolong remission, while nail involvement identifies patients at higher relapse risk, supporting closer monitoring and individualized follow‐up and maintenance strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisUltraviolet TherapyCalcitriolDermatologic AgentsHumansMaleChildFemaleAdolescentRetrospective StudiesRecurrence

Stichwörter der Autor:innen

nail involvementnarrowband UVBpediatric psoriasisphototherapyrelapsetopical corticosteroids

Substanzen

calcipotrieneCalcitriolDermatologic Agents

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Türkiye.
  • Department of Dermatology, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, İstanbul, Türkiye.
  • Department of Dermatology, Sakarya Training and Research Hospital, Sakarya, Türkiye.
  • Department of Dermatology, Health Sciences University, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
  • Department of Dermatology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye.
  • Department of Dermatology, Faculty of Medicine, Mersin University, Mersin, Türkiye.

ORCID-Profile: Berna Solak, Burhan Engin, Zeynep Güngör, Ömer Faruk Tolun, Zafer Türkoğlu, Dilay Baştuğ, Harbiye Dilek Canat, Tubanur Çetinarslan, Aylin Türel Ermertcan, Selen Gezmen, Özge Zorlu, Hülya Albayrak, Nazlı Caf, Ümit Türsen

Zitieren

APA

Solak, B., Engin, B., Güngör, Z., Tolun, Ö. F., Türkoğlu, Z., Baştuğ, D., Canat, H. D., Çetinarslan, T., Ermertcan, A. T., Gezmen, S., Zorlu, Ö., Albayrak, H., Caf, N., & Türsen, Ü. (2026). Real‐World Predictors of Relapse‐Free Duration After Narrowband UVB in Pediatric Psoriasis: A Multicenter Study. Photodermatology, Photoimmunology & Photomedicine, 42(2). https://doi.org/10.1111/phpp.70076

Vancouver

Solak B, Engin B, Güngör Z, Tolun ÖF, Türkoğlu Z, Baştuğ D, et al. Real‐World Predictors of Relapse‐Free Duration After Narrowband UVB in Pediatric Psoriasis: A Multicenter Study. Photodermatology, Photoimmunology & Photomedicine. 2026;42(2). doi:10.1111/phpp.70076

BibTeX
@article{Solak2026,
  author = {Solak, Berna and Engin, Burhan and Güngör, Zeynep and Tolun, Ömer Faruk and Türkoğlu, Zafer and Baştuğ, Dilay and Canat, Harbiye Dilek and Çetinarslan, Tubanur and Ermertcan, Aylin Türel and Gezmen, Selen and Zorlu, Özge and Albayrak, Hülya and Caf, Nazlı and Türsen, Ümit},
  title = {Real‐World Predictors of Relapse‐Free Duration After Narrowband UVB in Pediatric Psoriasis: A Multicenter Study},
  journal = {Photodermatology, Photoimmunology & Photomedicine},
  year = {2026},
  volume = {42},
  number = {2},
  doi = {10.1111/phpp.70076}
}
Kostenlos starten →